Predicting the progression of difficult-to-treat rheumatoid arthritis by a machine learning scoring system, from the FIRST registry.
Masanobu Ueno; Koshiro Sonomoto; Hiroaki Tanaka; Atsushi Nagayasu; Takafumi Aritomi; Ippei Miyagawa; Satoshi Kubo; Yusuke Miyazaki; Yasuyuki Todoroki; Yurie Satoh-Kanda; Yuya Fujita; Hidenori Sakai; Shingo Nakayamada; Yoshiya Tanaka
RMD open, Jan. 2026

Transition of clinical remission rates with molecular targeted therapies in rheumatoid arthritis in Japan: insights from the FIRST registry.
Satoshi Kubo; Yusuke Miyazaki; Hiroaki Tanaka; Yuya Fujita; Hidenori Sakai; Masanobu Ueno; Yasuyuki Todoroki; Yurie Satoh-Kanda; Ippei Miyagawa; Shingo Nakayamada; Yoshiya Tanaka
Rheumatology (Oxford, England), Sep. 2025

Influence of Rheumatoid Factors on the Efficacy of TNF Inhibitor Therapy in Patients with Rheumatoid Arthritis.
Atsushi Nagayasu; Yusuke Miyazaki; Koshiro Sonomoto; Satoshi Kubo; Ippei Miyagawa; Ayako Yamaguchi; Hiroaki Tanaka; Yasuyuki Todoroki; Masanobu Ueno; Takafumi Aritomi; Yuya Fujita; Hidenori Sakai; Katsunori Suzuki; Shingo Nakayamada; Yoshiya Tanaka
Rheumatology and therapy, Aug. 2025

Early effects of ozoralizumab 30 mg in patients with rheumatoid arthritis and inadequate response to methotrexate: a post hoc trajectory analysis of the phase II/III OHZORA trial.
Yusuke Miyazaki; Nobuko Horiuchi; Shunsuke Okamoto; Rumiko Matsumoto; Tsutomu Takeuchi; Yoshiya Tanaka
RMD open, Jun. 2025

Predictors of the effectiveness of first-line CTLA4-Ig in patients with RA: the FIRST registry.
Hiroki Kobayashi; Yusuke Miyazaki; Shingo Nakayamada; Kentaro Hanami; Shunsuke Fukuyo; Satoshi Kubo; Ayako Yamaguchi; Yoshino Inoue; Yasuyuki Todoroki; Hiroko Miyata; Hiroaki Tanaka; Yoshihisa Fujino; Shintaro Hirata; Yoshiya Tanaka
Rheumatology (Oxford, England), May 2025

Effective Second-Line b/tsDMARDs for Patients with Rheumatoid Arthritis Unresponsive to First-Line b/tsDMARDs from the FIRST Registry.
Ryuichiro Kanda; Yusuke Miyazaki; Shingo Nakayamada; Shunsuke Fukuyo; Satoshi Kubo; Ippei Miyagawa; Ayako Yamaguchi; Yurie Satoh-Kanda; Naoaki Ohkubo; Yasuyuki Todoroki; Hiroaki Tanaka; Masanobu Ueno; Atsushi Nagayasu; Yuya Fujita; Takafumi Aritomi; Katsuhide Kusaka; Hidenori Sakai; Satsuki Matsunaga; Hirotsugu Nohara; Yoshiya Tanaka
Rheumatology and therapy, Apr. 2025

Efficacy, safety and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry.
Hidenori Sakai; Yusuke Miyazaki; Shingo Nakayamada; Satoshi Kubo; Kentaro Hanami; Shunsuke Fukuyo; Ayako Yamaguchi; Ippei Miyagawa; Masanobu Ueno; Hiroaki Tanaka; Yasuyuki Todoroki; Naoaki Ohkubo; Masashi Funada; Satsuki Matsunaga; Yoshiya Tanaka
Rheumatology (Oxford, England), Apr. 2025

Comparison of anti-IL-6 receptor and JAK inhibitors in patients with rheumatoid arthritis from the real-world practice FIRST registry.
Yusuke Miyazaki; Shingo Nakayamada; Hiroaki Tanaka; Kentaro Hanami; Shunsuke Fukuyo; Satoshi Kubo; Ippei Miyagawa; Ayako Yamaguchi; Yasuyuki Todoroki; Yoshino Inoue; Masanobu Ueno; Yoshiya Tanaka
Rheumatology (Oxford, England), Apr. 2025

Switching to biological DMARDs versus cycling among JAK inhibitors in patients with rheumatoid arthritis and with inadequate response to JAK inhibitors: from FIRST registry.
Yusuke Miyazaki; Shingo Nakayamada; Hiroaki Tanaka; Kentaro Hanami; Shunsuke Fukuyo; Satoshi Kubo; Ayako Yamaguchi; Ippei Miyagawa; Yurie Satoh-Kanda; Yasuyuki Todoroki; Yoshino Inoue; Masanobu Ueno; Yoshiya Tanaka
RMD open, Jan. 2025

Safety and efficacy of anifrolumab therapy in systemic lupus erythematosus in real-world clinical practice: LOOPS registry
Miyazaki, Y.; Funada, M.; Nakayamada, S.; Sonomoto, K.; Tanaka, H.; Hanami, K.; Fukuyo, S.; Kubo, S.; Yamaguchi, A.; Miyagawa, I.; Todoroki, Y.; Ueno, M.; Tanaka, Y.
Rheumatology (United Kingdom), 2024

Efficacy and Safety of Biologics in Polymyalgia Rheumatica: A Retrospective Study
Ohkubo, N.; Miyazaki, Y.; Nakayamada, S.; Fukuyo, S.; Inoue, Y.; Satoh-Kanda, Y.; Tanaka, H.; Todoroki, Y.; Miyata, H.; Nagayasu, A.; Funada, M.; Kobayashi, H.; Sakai, H.; Kosaka, S.; Matsunaga, S.; Tomoyose, Y.; Nohara, H.; Tanaka, Y.
Rheumatology and Therapy, 2024

Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness
Kubo, S.; Miyazaki, Y.; Nishino, T.; Fujita, Y.; Kono, M.; Kawashima, T.; Ishigaki, K.; Kusaka, K.; Tanaka, H.; Ueno, M.; Satoh-Kanda, Y.; Inoue, Y.; Todoroki, Y.; Miyagawa, I.; Hanami, K.; Nakayamada, S.; Tanaka, Y.
Annals of the Rheumatic Diseases, 2024

CT informs detection and treatment options in rheumatoid arthritis complicated by pulmonary non-Tuberculous mycobacterial disease from the FIRST registry
Funada, M.; Miyazaki, Y.; Nakayamada, S.; Sonomoto, K.; Kubo, S.; Miyagawa, I.; Tanaka, H.; Tanaka, Y.
RMD Open, 2024

Extracting immunological and clinical heterogeneity across autoimmune rheumatic diseases by cohort-wide immunophenotyping
Tanaka, H.; Okada, Y.; Nakayamada, S.; Miyazaki, Y.; Sonehara, K.; Namba, S.; Honda, S.; Shirai, Y.; Yamamoto, K.; Kubo, S.; Ikari, K.; Harigai, M.; Sonomoto, K.; Tanaka, Y.
Annals of the Rheumatic Diseases, 2024

Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study
Sonomoto, K.; Nakayamada, S.; Fujino, Y.; Miyata, H.; Kubo, S.; Fujita, Y.; Inoue, Y.; Matsunaga, S.; Iwata, S.; Hanami, K.; Todoroki, Y.; Yoshinari-Korekoda, H.; Kawabe, A.; Yamaguchi, A.; Ueno, M.; Satoh-Kanda, Y.; Kanda, R.; Funada, M.; Ohkubo, N.; Kusaka, K.; Kosaka, S.; Nagayasu, A.; Fukuyo, S.; Nawata, M.; Miyazaki, Y.; Tokunaga, M.; Tanaka, K.; Okada, Y.; Tanaka, Y.
Rheumatology (United Kingdom), 2024

Induction of interleukin 21 receptor expression via enhanced intracellular metabolism in B cells and its relevance to the disease activity in systemic lupus erythematosus
Ueno, M.; Iwata, S.; Yamagata, K.; Todoroki, Y.; Sonomoto, K.; Nagayasu, A.; Miyagawa, I.; Kubo, S.; Miyazaki, Y.; Miyata, H.; Kanda, R.; Aritomi, T.; Nakayamada, S.; Tanaka, Y.
RMD Open, 2024

Correction: Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes (Arthritis Research & Therapy, (2022), 24, 1, (240), 10.1186/s13075-022-02934-3)
Ueno, M.; Miyagawa, I.; Miyazaki, Y.; Hanami, K.; Fukuyo, S.; Kubo, S.; Nakayamada, S.; Tanaka, Y.
Arthritis Research and Therapy, 2023

Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry
Kubo, S.; Miyazaki, Y.; Todoroki, Y.; Nagayasu, A.; Kanda, R.; Aritomi, T.; Matsunaga, S.; Ueno, M.; Miyagawa, I.; Sonomoto, K.; Hanami, K.; Nakayamada, S.; Tanaka, Y.
Rheumatology and Therapy, 2023

Sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis (XANADU study): an open-label randomised study
Kubo, S.; Miyazaki, Y.; Amano, K.; Matsui, K.; Kameda, H.; Inoue, Y.; Nakayamada, S.; Ogura, T.; Kaneko, Y.; Yamaoka, K.; Tanaka, Y.
RMD Open, 2023

Computed tomography for malignancy screening in patients with rheumatoid arthritis before initiation of disease modifying antirheumatic drug
Miyata, H.; Sonomoto, K.; Fukuyo, S.; Nakayamada, S.; Nakano, K.; Iwata, S.; Miyazaki, Y.; Kawabe, A.; Aoki, T.; Tanaka, Y.
Rheumatology (United Kingdom), 2023

Down-regulated Th17 cells in a patient with familial Mediterranean fever associated with amyloid A amyloidosis in the treatment of canakinumab
Goto, T.; Miyazaki, Y.; Nakayamada, S.; Shiraishi, N.; Yoshinaga, T.; Tanaka, Y.; Nakamura, T.
Modern Rheumatology Case Reports, 2023

Differential expression of IFN-α, IL-12 and BAFF on renal immune cells and its relevance to disease activity and treatment responsiveness in patients with proliferative lupus nephritis
Nawata, A.; Nakayamada, S.; Hisano, S.; Miyazaki, Y.; Miyamoto, T.; Shiba, E.; Hisaoka, M.; Tanaka, Y.
Lupus Science and Medicine, 2023

Reduced homovanillic acid, SDF-1α and SCGF-β levels in cerebrospinal fluid are related to depressive states in systemic lupus erythematosus
Fujita, Y.; Iwata, S.; Hidese, S.; Ishiwata, S.; Ide, S.; Tanaka, H.; Sonomoto, K.; Miyazaki, Y.; Nakayamada, S.; Ikenouchi, A.; Hattori, K.; Kunugi, H.; Yoshimura, R.; Tanaka, Y.
Rheumatology (United Kingdom), 2023

Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study
Ueno, M.; Miyagawa, I.; Aritomi, T.; Kimura, K.; Iwata, S.; Hanami, K.; Fukuyo, S.; Kubo, S.; Miyazaki, Y.; Nakayamada, S.; Tanaka, Y.
Arthritis Research and Therapy, 2022

T helper cells expressing fractalkine receptor and bearing T follicular helper 1-like cell functions in patients with IgG4-related disease
Inoue, Y.; Nakayamada, S.; Kubo, S.; Yamagata, K.; Sonomoto, K.; Iwata, S.; Miyazaki, Y.; Tanaka, Y.
Rheumatology (United Kingdom), 2022

Impact of serum interleukin-22 as a biomarker for the differential use of molecular targeted drugs in psoriatic arthritis: a retrospective study
Miyagawa, I.; Nakayamada, S.; Ueno, M.; Miyazaki, Y.; Iwata, S.; Kubo, S.; Sonomoto, K.; Anan, J.; Ohkubo, N.; Inoue, Y.; Tanaka, Y.
Arthritis Research and Therapy, 2022

mTOR activation in CD8⁺ cells contributes to disease activity of rheumatoid arthritis and increases therapeutic response to TNF inhibitors
Zhang, M.; Iwata, S.; Sonomoto, K.; Ueno, M.; Fujita, Y.; Anan, J.; Miyazaki, Y.; Ohkubo, N.; Sumikawa, M.H.; Todoroki, Y.; Miyata, H.; Nagayasu, A.; Kanda, R.; Hao, H.; Trimova, G.; Lee, S.; Nakayamada, S.; Sakata, K.; Tanaka, Y.
Rheumatology (United Kingdom), 2022

Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTD
Todoroki, Y.; Kubo, S.; Nakano, K.; Miyazaki, Y.; Ueno, M.; Satoh-Kanda, Y.; Kanda, R.; Miyagawa, I.; Hanami, K.; Nakatsuka, K.; Saito, K.; Nakayamada, S.; Tanaka, Y.
Rheumatology (United Kingdom), 2022

Precision medicine based on the phenotypic differences in peripheral T helper cells in patients with psoriatic arthritis: One year follow-up outcomes
Miyagawa, I.; Nakayamada, S.; Ueno, M.; Miyazaki, Y.; Ohkubo, N.; Inoue, Y.; Kubo, S.; Tanaka, Y.
Frontiers in Medicine, 2022

Efficacy and safety of high-dose of mycophenolate mofetil compared with cyclophosphamide pulse therapy as induction therapy in Japanese patients with proliferative lupus nephritis
Ohkubo, N.; Iwata, S.; Nakano, K.; Miyagawa, I.; Hanami, K.; Fukuyo, S.; Miyazaki, Y.; Kawabe, A.; Nakayamada, S.; Tanaka, Y.
Modern Rheumatology, 2022

A case of mixed connective tissue disease complicated by pulmonary hypertension and ascites after addition of pulmonary vasodilators
Kusaka, K.; Nakano, K.; Fukuyo, S.; Miyazaki, Y.; Matsunaga, S.; Tanaka, Y.
Modern Rheumatology Case Reports, 2022

Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes
Ueno, M.; Miyagawa, I.; Miyazaki, Y.; Hanami, K.; Fukuyo, S.; Kubo, S.; Nakayamada, S.; Tanaka, Y.
Arthritis Research and Therapy, 2022

A case of simultaneous onset of highly active systemic lupus erythematosus and IgG4-related renal disease
Fujita, Y.; Iwata, S.; Nakano, K.; Nakayamada, S.; Miyazaki, Y.; Kawabe, A.; Korekoda-Yoshinari, H.; Nawata, A.; Tanaka, Y.
Modern Rheumatology Case Reports, 2022

Efficacy and safety of belimumab during maintenance therapy in patients with systemic lupus erythematosus
Miyazaki, Y.; Nakayamada, S.; Sonomoto, K.; Kawabe, A.; Inoue, Y.; Okubo, N.; Iwata, S.; Hanami, K.; Tanaka, Y.
Rheumatology (United Kingdom), 2022

Eosinophilic granulomatosis with polyangiitis exhibits T cell activation and IgG4 immune response in the tissue; Comparison with IgG4-related disease
Kubo, S.; Kanda, R.; Nawata, A.; Miyazaki, Y.; Kawabe, A.; Hanami, K.; Nakatsuka, K.; Saito, K.; Nakayamada, S.; Tanaka, Y.
RMD Open, 2022

Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: Analyses with propensity score-based inverse probability of treatment weighting
Miyazaki, Y.; Nakano, K.; Nakayamada, S.; Kubo, S.; Inoue, Y.; Fujino, Y.; Tanaka, Y.
Annals of the Rheumatic Diseases, 2021

Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis
Ueno, M.; Miyagawa, I.; Nakano, K.; Iwata, S.; Hanami, K.; Fukuyo, S.; Kubo, S.; Miyazaki, Y.; Kawabe, A.; Yoshinari, H.; Nakayamada, S.; Tanaka, Y.
Arthritis Research and Therapy, 2021

Serum TNFα levels at 24 h after certolizumab pegol predict effectiveness at week 12 in patients with rheumatoid arthritis from TSUBAME study
Miyazaki, Y.; Nakano, K.; Nakayamada, S.; Kubo, S.; Iwata, S.; Hanami, K.; Fukuyo, S.; Miyagawa, I.; Yamaguchi, A.; Kawabe, A.; Saito, K.; Tanaka, Y.
Arthritis Research and Therapy, 2021

Fulminant type 1 diabetes with diversity in peripheral blood lymphocytes: A case report
Kurozumi, A.; Okada, Y.; Miyazaki, Y.; Nakayamada, S.; Tanaka, Y.
Journal of UOEH, 2020

The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus
Miyagawa, I.; Nakano, K.; Nakayamada, S.; Iwata, S.; Hanami, K.; Fukuyo, S.; Kubo, S.; Kawabe, A.; Miyazaki, Y.; Inoue, Y.; Ueno, M.; Ohkubo, N.; Fujita, Y.; Tanaka, Y.
International Journal of Rheumatic Diseases, 2020

Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation
Miyazaki, Y.; Nakayamada, S.; Kubo, S.; Ishikawa, Y.; Yoshikawa, M.; Sakata, K.; Sakata, K.; Iwata, S.; Miyagawa, I.; Nakano, K.; Tanaka, Y.
Arthritis Research and Therapy, 2020

Enhanced Fatty Acid Synthesis Leads to Subset Imbalance and IFN-γ Overproduction in T Helper 1 Cells
Iwata, S.; Zhang, M.; Hao, H.; Trimova, G.; Hajime, M.; Miyazaki, Y.; Ohkubo, N.; Satoh Kanda, Y.; Todoroki, Y.; Miyata, H.; Ueno, M.; Nagayasu, A.; Nakayamada, S.; Sakata, K.; Tanaka, Y.
Frontiers in Immunology, 2020

The two cases of acute acalculous cholecystitis associated with systemic lupus erythematosus (SLE) presented different clinical aspects
Satoh, Y.; Nakano, K.; Miyazaki, Y.; Nakayamada, S.; Fukuyo, S.; Kubo, S.; Miyagawa, I.; Yoshinari, H.; Saito, K.; Satoh, M.; Tanaka, Y.
Modern Rheumatology Case Reports, 2019

Distinctive association of peripheral immune cell phenotypes with capillaroscopic microvascular patterns in systemic sclerosis
Kubo, S.; Nakayamada, S.; Miyazaki, Y.; Yoshikawa, M.; Yoshinari, H.; Satoh, Y.; Todoroki, Y.; Nakano, K.; Satoh, M.; Smith, V.; Cutolo, M.; Tanaka, Y.
Rheumatology (United Kingdom), 2019

Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet's disease
Miyagawa, I.; Nakano, K.; Iwata, S.; Nakayamada, S.; Saito, K.; Hanami, K.; Fukuyo, S.; Kubo, S.; Kawabe, A.; Miyazaki, Y.; Tanaka, Y.
Arthritis research & therapy, 2019

Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis
Miyagawa, I.; Nakayamada, S.; Nakano, K.; Kubo, S.; Iwata, S.; Miyazaki, Y.; Yoshikawa, M.; Yoshinari, H.; Tanaka, Y.
Rheumatology (United Kingdom), 2019

Expansion of T follicular helper-T helper 1 like cells through epigenetic regulation by signal transducer and activator of transcription factors
Ma, X.; Nakayamada, S.; Kubo, S.; Sakata, K.; Yamagata, K.; Miyazaki, Y.; Yoshikawa, M.; Kitanaga, Y.; Zhang, M.; Tanaka, Y.
Annals of the Rheumatic Diseases, 2018

Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus
Iwata, S.; Saito, K.; Hirata, S.; Ohkubo, N.; Nakayamada, S.; Nakano, K.; Hanami, K.; Kubo, S.; Miyagawa, I.; Yoshikawa, M.; Miyazaki, Y.; Yoshinari, H.; Tanaka, Y.
Lupus, 2018

Th22 Cells Promote Osteoclast Differentiation via Production of IL-22 in Rheumatoid Arthritis
Miyazaki, Y.; Nakayamada, S.; Kubo, S.; Nakano, K.; Iwata, S.; Miyagawa, I.; Ma, X.; Trimova, G.; Sakata, K.; Tanaka, Y.
Frontiers in Immunology, 2018

Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus
Sakata, K.; Nakayamada, S.; Miyazaki, Y.; Kubo, S.; Ishii, A.; Nakano, K.; Tanaka, Y.
Frontiers in Immunology, 2018

A case of refractory lupus nephritis complicated by psoriasis vulgaris that was controlled with secukinumab
Satoh, Y.; Nakano, K.; Yoshinari, H.; Nakayamada, S.; Iwata, S.; Kubo, S.; Miyagawa, I.; Yoshikawa, M.; Miyazaki, Y.; Saito, K.; Tanaka, Y.
Lupus, 2018

Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with igG4-related disease
Kubo, S.; Nakayamada, S.; Zhao, J.; Yoshikawa, M.; Miyazaki, Y.; Nawata, A.; Hirata, S.; Nakano, K.; Saito, K.; Tanaka, Y.
Rheumatology (United Kingdom), 2018

Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis
Nakayamada, S.; Kubo, S.; Yoshikawa, M.; Miyazaki, Y.; Yunoue, N.; Iwata, S.; Miyagawa, I.; Hirata, S.; Nakano, K.; Saito, K.; Tanaka, Y.
Rheumatology (United Kingdom), 2018

Peripheral Immunophenotyping Identifies Three Subgroups Based on T Cell Heterogeneity in Lupus Patients
Kubo, S.; Nakayamada, S.; Yoshikawa, M.; Miyazaki, Y.; Sakata, K.; Nakano, K.; Hanami, K.; Iwata, S.; Miyagawa, I.; Saito, K.; Tanaka, Y.
Arthritis and Rheumatology, 2017

Metabolic reprogramming commits differentiation of human CD27⁺IgD⁺ B cells to plasmablasts or CD27^-IgD^- cells
Torigoe, M.; Iwata, S.; Nakayamada, S.; Sakata, K.; Zhang, M.; Hajime, M.; Miyazaki, Y.; Narisawa, M.; Ishii, K.; Shibata, H.; Tanaka, Y.
Journal of Immunology, 2017

Pancreas-protective effect of rituximab for acute-onset type 1 diabetes in the honeymoon period: A case report
Kurozumi, A.; Okada, Y.; Arao, T.; Miyazaki, Y.; Yoshikawa, M.; Torimoto, K.; Kubo, S.; Nakayamada, S.; Tanaka, Y.
Endocrinology, Diabetes and Metabolism Case Reports, 2016

A case of adenosquamous lung carcinoma with dermatomyositis as a paraneoplastic syndrome
Tomoda, Y.; Haruta, Y.; Mei, T.; Miyazaki, Y.; Yoke, H.
Japanese Journal of Lung Cancer, 2013

高疾患活動性のSLE患者に対するustekinumabの有効性と安全性　全身性エリテマトーデス患者を対象としたustekinumabの有効性と安全性を評価する第III相多施設共同無作為化プラセボ比較試験(LOTUS試験)から
宮崎 佑介, 田中 良哉
リウマチ科, Apr. 2023, Reviewed, No invitation
Lead

実臨床下においてヤヌスキナーゼ阻害薬ごとの有効性と安全性に差はあるのか?　実臨床下における関節リウマチ患者に対するtofacitinibとbaricitinibの有効性と安全性の比較　傾向スコアに基づく逆確率重み付け法による解析から
宮﨑佑介, 田中良哉
リウマチ科, Sep. 2022, Reviewed, No invitation
Lead

COVID-19罹患後に発症した重症心筋炎の一例
日下 勝秀, 大久保 直紀, 中山田 真吾, 宮崎 佑介, 松永 五月, 田中 良哉
九州リウマチ, Sep. 2024, Reviewed, No invitation

巨細胞性動脈炎と好酸球性多発血管炎性肉芽腫症を合併した多発血管炎重複症候群の一例
有冨 貴史, 中野 和久, 河邊 明男, 今林 慶祐, 名和田 彩, 宮崎 佑介, 中山田 真吾, 田中 良哉
九州リウマチ, Sep. 2021, Reviewed, No invitation

家族性地中海熱(FMF)非典型例としてカナキヌマブ治療中に、ベーチェット病の症状が顕在化し、アダリムマブが奏功した一例
小坂 峻平, 中野 和久, 宮崎 佑介, 中山田 真吾, 岩田 慈, 河邊 明男, 吉成 紘子, 田中 良哉
九州リウマチ, Sep. 2020, Reviewed, No invitation

強直性脊椎炎に対してTNF-α阻害薬で加療中に発症した掌蹠膿疱症の2症例
有冨 貴史, 中野 和久, 吉成 紘子, 中山田 真吾, 岩田 慈, 福與 俊介, 宮川 一平, 河邊 明男, 宮崎 佑介, 上野 匡庸, 田中 良哉
九州リウマチ, Mar. 2020, Reviewed, No invitation

無症候性IgG4関連胆嚢炎を伴ったIgG4関連疾患の一例
日下 勝秀, 中野 和久, 吉成 紘子, 岩田 慈, 福與 俊介, 花見 健太郎, 久保 智史, 宮川 一平, 河邊 明男, 宮崎 佑介, 名和田 彩, 井上 嘉乃, 上野 匡庸, 有冨 貴史, 中山田 真吾, 田中 良哉
九州リウマチ, Mar. 2019, Reviewed, No invitation

【既存の生物学的製剤を総括する】 セルトリズマブペゴル
宮崎 佑介, 中野 和久, 田中 良哉
分子リウマチ治療, Jul. 2018, Reviewed, Null
Lead

【膠原病で期待される標的療法〜効果と今後への展望〜】BAFF阻害薬の作用機序、使い方と今後の展望
宮崎 佑介, 中山田 真吾, 田中 良哉
炎症と免疫, Jun. 2021, Reviewed, No invitation
Lead

ヒト免疫細胞の新しい解析手法(第2回)　ヒト免疫細胞のマルチカラーフローサイトメトリー解析
中山田 真吾, 宮崎 佑介, 田中 良哉
炎症と免疫, Aug. 2020, Reviewed, No invitation

末梢血リンパ球の多様性が推測された劇症1型糖尿病の1症例(Fulminant Type 1 Diabetes with Diversity in Peripheral Blood Lymphocytes: A Case Report)
黒住 旭, 岡田 洋右, 宮崎 佑介, 中山田 真吾, 田中 良哉
産業医科大学雑誌, Mar. 2020, Null, Null

Extracting immunological and clinical heterogeneity across autoimmune rheumatic diseases by cohort-wide immunophenotyping.
Tanaka H, Okada Y, Nakayamada S, Miyazaki Y, Sonehara K, Namba S, Honda S, Shirai Y, Yamamoto K, Kubo S, Ikari K, Harigai M, Sonomoto K, Tanaka Y.
Annals of the Rheumatic Diseases, Oct. 2023, Reviewed, No invitation

Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness.
Kubo Satoshi, Miyazaki Yusuke, Nishino Takahiro, Fujita Yuya, Kono Michihiro, Kawashima Tsugumi, Ishigaki Kazuyoshi, Kusaka Katsuhide, Tanaka Hiroaki, Ueno Masanobu, Satoh-Kanda Yurie, Inoue Yoshino, Todoroki Yasuyuki, Miyagawa Ippei, Hanami Kentaro, Nakayamada Shingo, Tanaka Yoshiya
Annals of the rheumatic diseases, Oct. 2024, Reviewed, No invitation

Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness.
Kubo Satoshi, Miyazaki Yusuke, Nishino Takahiro, Fujita Yuya, Kono Michihiro, Kawashima Tsugumi, Ishigaki Kazuyoshi, Kusaka Katsuhide, Tanaka Hiroaki, Ueno Masanobu, Satoh-Kanda Yurie, Inoue Yoshino, Todoroki Yasuyuki, Miyagawa Ippei, Hanami Kentaro, Nakayamada Shingo, Tanaka Yoshiya
Annals of the rheumatic diseases, Feb. 2025, Reviewed, No invitation

Extracting immunological and clinical heterogeneity across autoimmune rheumatic diseases by cohort-wide immunophenotyping.
Tanaka Hiroaki, Okada Yukinori, Nakayamada Shingo, Miyazaki Yusuke, Sonehara Kyuto, Namba Shinichi, Honda Suguru, Shirai Yuya, Yamamoto Kenichi, Kubo Satoshi, Ikari Katsunori, Harigai Masayoshi, Sonomoto Koshiro, Tanaka Yoshiya
Annals of the rheumatic diseases, Jan. 2024, Reviewed, No invitation

Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: analyses with propensity score-based inverse probability of treatment weighting.
Miyazaki Yusuke, Nakano Kazuhisa, Nakayamada Shingo, Kubo Satoshi, Inoue Yoshino, Fujino Yoshihisa, Tanaka Yoshiya
Annals of the rheumatic diseases, Sep. 2021, Reviewed, No invitation
Lead

Expansion of T follicular helper-T helper 1 like cells through epigenetic regulation by signal transducer and activator of transcription factors.
Ma Xiaoxue, Nakayamada Shingo, Kubo Satoshi, Sakata Kei, Yamagata Kaoru, Miyazaki Yusuke, Yoshikawa Maiko, Kitanaga Yukihiro, Zhang Mingzeng, Tanaka Yoshiya
Annals of the rheumatic diseases, Sep. 2018, Reviewed, No invitation

Peripheral immunophenotyping identifies three subgroups based on T cell heterogeneity in lupus patients.
Kubo Satoshi, Nakayamada Shingo, Yoshikawa Maiko, Miyazaki Yusuke, Sakata Kei, Nakano Kazuhisa, Hanami Kentaro, Iwata Shigeru, Miyagawa Ippei, Saito Kazuyoshi, Tanaka Yoshiya
Arthritis & rheumatology (Hoboken, N.J.), Jun. 2017, Reviewed, No invitation

Accelerated Type VII collagen turnover in systemic sclerosis patients, reflected by serological neo-epitope fragment biomarkers.
He Yi, Sand Jannie M B, Kubo Satoshi, Ohkubo Naoaki, Miyazaki Yusuke, Karsdal Morten, Tanaka Yoshiya, Bay-Jensen Anne-Christine
Arthritis research & therapy, Mar. 2025, Reviewed, No invitation

Impact of serum interleukin-22 as a biomarker for the differential use of molecular targeted drugs in psoriatic arthritis: a retrospective study.
Miyagawa Ippei, Nakayamada Shingo, Ueno Masanobu, Miyazaki Yusuke, Iwata Shigeru, Kubo Satoshi, Sonomoto Koshiro, Anan Junpei, Ohkubo Naoaki, Inoue Yoshino, Tanaka Yoshiya
Arthritis research & therapy, Apr. 2022, Reviewed, No invitation

Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes.
Ueno Masanobu, Miyagawa Ippei, Miyazaki Yusuke, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Nakayamada Shingo, Tanaka Yoshiya
Arthritis research & therapy, Oct. 2022, Reviewed, No invitation

Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study
Masanobu Ueno, Ippei Miyagawa, Takafumi Aritomi, Koichi Kimura, Shigeru Iwata, Kentaro Hanami, Syunsuke Fukuyo, Satoshi Kubo, Yusuke Miyazaki, Shingo Nakayamada, Yoshiya Tanaka
Arthritis research & therapy, Jun. 2022, Reviewed, No invitation

Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis.
Ueno Masanobu, Miyagawa Ippei, Nakano Kazuhisa, Iwata Shigeru, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Miyazaki Yusuke, Kawabe Akio, Yoshinari Hiroko, Nakayamada Shingo, Tanaka Yoshiya
Arthritis research & therapy, Mar. 2021, Reviewed, No invitation

Serum TNFα levels at 24 h after certolizumab pegol predict effectiveness at week 12 in patients with rheumatoid arthritis from TSUBAME study.
Miyazaki Yusuke, Nakano Kazuhisa, Nakayamada Shingo, Kubo Satoshi, Iwata Shigeru, Hanami Kentaro, Fukuyo Shunsuke, Miyagawa Ippei, Yamaguchi Ayako, Kawabe Akio, Saito Kazuyoshi, Tanaka Yoshiya
Arthritis research & therapy, Jun. 2021, Reviewed, No invitation
Lead

Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation.
Miyazaki Yusuke, Nakayamada Shingo, Kubo Satoshi, Ishikawa Yuichi, Yoshikawa Maiko, Sakata Kei, Iwata Shigeru, Miyagawa Ippei, Nakano Kazuhisa, Tanaka Yoshiya
Arthritis research & therapy, Jun. 2020, Reviewed, No invitation
Lead

Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet's disease.
Miyagawa Ippei, Nakano Kazuhisa, Iwata Shigeru, Nakayamada Shingo, Saito Kazuyoshi, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Kawabe Akio, Miyazaki Yusuke, Tanaka Yoshiya
Arthritis research & therapy, Jun. 2019, Reviewed, No invitation

Reduction of non-classical monocytes that suppress interferon-α in patients with systemic lupus erythematosus.
Ishii Akina, Nakayamada Shingo, Ohkubo Naoaki, Miyazaki Yusuke, Iwata Shigeru, Annan Junpei, Hashimoto Naohiro, Sakata Kei, Tanaka Yoshiya
Clinical and experimental rheumatology, Apr. 2025, Reviewed, No invitation

Th22 Cells Promote Osteoclast Differentiation via Production of IL-22 in Rheumatoid Arthritis.
Miyazaki Yusuke, Nakayamada Shingo, Kubo Satoshi, Nakano Kazuhisa, Iwata Shigeru, Miyagawa Ippei, Ma Xiaoxue, Trimova Gulzhan, Sakata Kei, Tanaka Yoshiya
Frontiers in immunology, Dec. 2018, Reviewed, No invitation
Lead

Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
Sakata Kei, Nakayamada Shingo, Miyazaki Yusuke, Kubo Satoshi, Ishii Akina, Nakano Kazuhisa, Tanaka Yoshiya
Frontiers in immunology, Aug. 2018, Reviewed, No invitation

Enhanced Fatty Acid Synthesis Leads to Subset Imbalance and IFN-γ Overproduction in T Helper 1 Cells.
Iwata Shigeru, Zhang Mingzeng, Hao He, Trimova Gulzhan, Hajime Maiko, Miyazaki Yusuke, Ohkubo Naoaki, Satoh Kanda Yurie, Todoroki Yasuyuki, Miyata Hiroko, Ueno Masanobu, Nagayasu Atsushi, Nakayamada Shingo, Sakata Kei, Tanaka Yoshiya
Frontiers in immunology, Nov. 2020, Reviewed, No invitation

Precision medicine based on the phenotypic differences in peripheral T helper cells in patients with psoriatic arthritis: One year follow-up outcomes.
Miyagawa Ippei, Nakayamada Shingo, Ueno Masanobu, Miyazaki Yusuke, Ohkubo Naoaki, Inoue Yoshino, Kubo Satoshi, Tanaka Yoshiya
Frontiers in medicine, Jul. 2022, Reviewed, No invitation

The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.
Miyagawa Ippei, Nakano Kazuhisa, Nakayamada Shingo, Iwata Shigeru, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Kawabe Akio, Miyazaki Yusuke, Inoue Yoshino, Ueno Masanobu, Ohkubo Naoaki, Fujita Yuya, Tanaka Yoshiya
International journal of rheumatic diseases, Feb. 2020, Reviewed, No invitation

Fulminant Type 1 Diabetes with Diversity in Peripheral Blood Lymphocytes: A Case Report.
Kurozumi Akira, Okada Yosuke, Miyazaki Yusuke, Nakayamada Shingo, Tanaka Yoshiya
Journal of UOEH, Mar. 2020, Reviewed, No invitation

Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus.
Iwata S,Saito K,Hirata S,Ohkubo N,Nakayamada S,Nakano K,Hanami K,Kubo S, Miyagawa I,Yoshikawa M,Miyazaki Y,Yoshinari H,Tanaka Y.
Lupus, Apr. 2018, Reviewed, No invitation

Impact of quality of life on overall work productivity impairment and activity impairment of patients with systemic lupus erythematosus: the PEONY study.
Tanaka Yoshiya, Miyazaki Yusuke, Hirata Shintaro, Kusaka Katsuhide, Kosaka Shunpei, Nakatsuka Keisuke, Saito Kazuyoshi, Iwata Shigeru, Yamaguchi Yoshiyuki, Yabe-Wada Toshiki, Fujiwara Masakazu, Arita Yoshifumi, Hoshino Mitsuru, Ozaki Naoko, Yamaoka Kunihiro, Nakayamada Shingo
Lupus science & medicine, Jan. 2025, Reviewed, No invitation

The two cases of acute acalculous cholecystitis associated with systemic lupus erythematosus (SLE) presented different clinical aspects
Satoh Y, Nakano K, Miyazaki Y, Nakayamada S, Fukuyo S, Kubo S, Miyagawa I, Yoshinari H, Saito K, Satoh M, Tanaka Y
Modern Rheumatology Case Reports, Jan. 2019, Reviewed, No invitation

The abundance of regulatory T cell subsets is associated with the clinical outcomes of sarcoidosis.
Kusaka Katsuhide, Miyazaki Yusuke, Nakayamada Shingo, Kubo Satoshi, Miyagawa Ippei, Satoh-Kanda Yurie, Todoroki Yasuyuki, Ueno Masanobu, Tanaka Yoshiya
Modern rheumatology, Apr. 2025, Reviewed, No invitation

Efficacy and Safety of High-Dose of Mycophenolate Mofetil Compared With Cyclophosphamide Pulse Therapy as Induction Therapy in Japanese Patients with Proliferative Lupus Nephritis.
Ohkubo Naoaki, Iwata Shigeru, Nakano Kazuhisa, Miyagawa Ippei, Hanami Kentaro, Fukuyo Shunsuke, Miyazaki Yusuke, Kawabe Akio, Nakayamada Shingo, Tanaka Yoshiya
Modern rheumatology, Oct. 2021, Reviewed, No invitation

Down-Regulated Th17 Cells in a Patient With Familial Mediterranean Fever Associated with AA Amyloidosis in the Treatment of Canakinumab.
Goto Takeshi, Miyazaki Yusuke, Nakayamada Shingo, Shiraishi Naoki, Yoshinaga Takeshi, Tanaka Yoshiya, Nakamura Tadashi
Modern rheumatology case reports, Mar. 2022, Reviewed, No invitation

Down-regulated Th17 cells in a patient with familial Mediterranean fever associated with amyloid A amyloidosis in the treatment of canakinumab
Takeshi Goto, Yusuke Miyazaki, Shingo Nakayamada, Naoki Shiraishi, Takeshi Yoshinaga, Yoshiya Tanaka, Tadashi Nakamura
Modern rheumatology case reports, Jan. 2023, Reviewed, No invitation

A Case of Mixed Connective Tissue Disease Complicated by Pulmonary Hypertension and Ascites After Addition of Pulmonary Vasodilators.
Kusaka Katsuhide, Nakano Kazuhisa, Fukuyo Shunsuke, Miyazaki Yusuke, Matsunaga Satsuki, Tanaka Yoshiya
Modern rheumatology case reports, Mar. 2022, Reviewed, No invitation

A Case of Simultaneous Onset of Highly Active Systemic Lupus Erythematosus and IgG4-Related Renal Disease.
Fujita Yuya, Iwata Shigeru, Nakano Kazuhisa, Nakayamada Shingo, Miyazaki Yusuke, Kawabe Akio, Korekoda-Yoshinari Hiroko, Nawata Aya, Tanaka Yoshiya
Modern rheumatology case reports, Jan. 2022, Reviewed, No invitation

Sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis (XANADU study): an open-label randomised study.
Kubo Satoshi, Miyazaki Yusuke, Amano Koichi, Matsui Kiyoshi, Kameda Hideto, Inoue Yoshino, Nakayamada Shingo, Ogura Takehisa, Kaneko Yuko, Yamaoka Kunihiro, Tanaka Yoshiya
RMD open, Apr. 2023, Reviewed, No invitation

Eosinophilic granulomatosis with polyangiitis exhibits T cell activation and IgG4 immune response in the tissue; comparison with IgG4-related disease.
Kubo Satoshi, Kanda Ryuichiro, Nawata Aya, Miyazaki Yusuke, Kawabe Akio, Hanami Kentaro, Nakatsuka Keisuke, Saito Kazuyoshi, Nakayamada Shingo, Tanaka Yoshiya
RMD open, Mar. 2022, Reviewed, No invitation

Switching to biological DMARDs versus cycling among JAK inhibitors in patients with rheumatoid arthritis and with inadequate response to JAK inhibitors: from FIRST registry.
Miyazaki Yusuke, Nakayamada Shingo, Tanaka Hiroaki, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Yamaguchi Ayako, Miyagawa Ippei, Satoh-Kanda Yurie, Todoroki Yasuyuki, Inoue Yoshino, Ueno Masanobu, Tanaka Yoshiya
RMD open, Jan. 2025, Reviewed, No invitation
Lead

Association of peripheral CD8+ T cell activation with disease activity and treatment resistance in systemic lupus erythematosus.
Fujita Yuya, Nakayamada Shingo, Kubo Satoshi, Miyazaki Yusuke, Sonomoto Koshiro, Tanaka Hiroaki, Tanaka Yoshiya
RMD open, Feb. 2025, Reviewed, No invitation

Induction of interleukin 21 receptor expression via enhanced intracellular metabolism in B cells and its relevance to the disease activity in systemic lupus erythematosus.
Ueno Masanobu, Iwata Shigeru, Yamagata Kaoru, Todoroki Yasuyuki, Sonomoto Koshiro, Nagayasu Atsushi, Miyagawa Ippei, Kubo Satoshi, Miyazaki Yusuke, Miyata Hiroko, Kanda Ryuichiro, Aritomi Takafumi, Nakayamada Shingo, Tanaka Yoshiya
RMD open, Dec. 2024, Reviewed, No invitation

Long-term safety and efficacy of anti-TNF multivalent VHH antibodies ozoralizumab in patients with rheumatoid arthritis.
Tanaka Yoshiya, Miyazaki Yusuke, Kawanishi Masafumi, Yamasaki Hironori, Takeuchi Tsutomu
RMD open, Aug. 2024, Reviewed, No invitation

CT informs detection and treatment options in rheumatoid arthritis complicated by pulmonary non-tuberculous mycobacterial disease from the FIRST registry.
Funada Masashi, Miyazaki Yusuke, Nakayamada Shingo, Sonomoto Koshiro, Kubo Satoshi, Miyagawa Ippei, Tanaka Hiroaki, Tanaka Yoshiya
RMD open, Jun. 2024, Reviewed, No invitation

Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis.
Nakayamada S, Kubo S, Yoshikawa M, Miyazaki Y, Yunoue N, Iwata S, Miyagawa I, Hirata S, Nakano S, Saito K, Tanaka Y.
Rheumatology, Apr. 2018, Reviewed, No invitation

Efficacy, safety, and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry.
Sakai Hidenori, Miyazaki Yusuke, Nakayamada Shingo, Kubo Satoshi, Hanami Kentaro, Fukuyo Shunsuke, Yamaguchi Ayako, Miyagawa Ippei, Ueno Masanobu, Tanaka Hiroaki, Todoroki Yasuyuki, Ohkubo Naoaki, Funada Masashi, Matsunaga Satsuki, Tanaka Yoshiya
Rheumatology (Oxford, England), Sep. 2024, Reviewed, No invitation

Comparison of anti-IL-6 receptor and JAK inhibitors in patients with rheumatoid arthritis from the real-world practice FIRST study.
Miyazaki Yusuke, Nakayamada Shingo, Tanaka Hiroaki, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Miyagawa Ippei, Yamaguchi Ayako, Todoroki Yasuyuki, Inoue Yoshino, Ueno Masanobu, Tanaka Yoshiya
Rheumatology (Oxford, England), Jun. 2024, Reviewed, No invitation
Lead

Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study.
Sonomoto Koshiro, Nakayamada Shingo, Fujino Yoshihisa, Miyata Hiroko, Kubo Satoshi, Fujita Yuya, Inoue Yoshino, Matsunaga Satsuki, Iwata Shigeru, Hanami Kentaro, Todoroki Yasuyuki, Yoshinari-Korekoda Hiroko, Kawabe Akio, Yamaguchi Ayako, Ueno Masanobu, Satoh-Kanda Yurie, Kanda Ryuichiro, Funada Masashi, Ohkubo Naoaki, Kusaka Katsuhide, Kosaka Shumpei, Nagayasu Atsushi, Fukuyo Shunsuke, Nawata Masao, Miyazaki Yusuke, Tokunaga Mikiko, Tanaka Kenichi, Okada Yosuke, Tanaka Yoshiya
Rheumatology (Oxford, England), Nov. 2023, Reviewed, No invitation

Safety and efficacy of anifrolumab therapy in systemic lupus erythematosus in real-world clinical practice: LOOPS registry.
Miyazaki Yusuke, Funada Masashi, Nakayamada Shingo, Sonomoto Koshiro, Tanaka Hiroaki, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Yamaguchi Ayako, Miyagawa Ippei, Todoroki Yasuyuki, Ueno Masanobu, Tanaka Yoshiya
Rheumatology (Oxford, England), Sep. 2024, Reviewed, No invitation
Lead

Predictors of the effectiveness to first-line CTLA4-Ig in patients with rheumatoid arthritis: the FIRST registry.
Kobayashi Hiroki, Miyazaki Yusuke, Nakayamada Shingo, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Yamaguchi Ayako, Inoue Yoshino, Todoroki Yasuyuki, Miyata Hiroko, Tanaka Hiroaki, Fujino Yoshihisa, Hirata Shintaro, Tanaka Yoshiya
Rheumatology (Oxford, England), May 2025, Reviewed, No invitation

Transition of clinical remission rates with molecular targeted therapies in rheumatoid arthritis in Japan: insights from FIRST registry.
Kubo Satoshi, Miyazaki Yusuke, Tanaka Hiroaki, Fujita Yuya, Sakai Hidenori, Ueno Masanobu, Todoroki Yasuyuki, Satoh-Kanda Yurie, Miyagawa Ippei, Nakayamada Shingo, Tanaka Yoshiya
Rheumatology (Oxford, England), May 2025, Reviewed, No invitation

T helper cells expressing fractalkine receptor and bearing T follicular helper 1-like cell functions in patients with IgG4-related disease.
Inoue Yoshino, Nakayamada Shingo, Kubo Satoshi, Yamagata Kaoru, Sonomoto Koshiro, Iwata Shigeru, Miyazaki Yusuke, Tanaka Yoshiya
Rheumatology (Oxford, England), Dec. 2021, Null, Null

Reduced homovanillic acid, SDF-1α, and SCGF-β levels in cerebrospinal fluid are related to depressive states in systemic lupus erythematosus
Yuya Fujita, Shigeru Iwata, Shinsuke Hidese, Sayuri Ishiwata, Satoru Ide, Hiroaki Tanaka, Koshiro Sonomoto, Yusuke Miyazaki, Shingo Nakayamada, Atsuko Ikenouchi, Kotaro Hattori, Hiroshi Kunugi, Reiji Yoshimura, Yoshiya Tanaka
Rheumatology (Oxford, England), Feb. 2023, Reviewed, No invitation

Computed tomography for malignancy screening in patients with rheumatoid arthritis before initiation of disease modifying antirheumatic drug.
Miyata Hiroko, Sonomoto Koshiro, Fukuyo Shunsuke, Nakayamada Shingo, Nakano Kazuhisa, Iwata Shigeru, Miyazaki Yusuke, Kawabe Akio, Aoki Takatoshi, Tanaka Yoshiya
Rheumatology (Oxford, England), Feb. 2023, Reviewed, No invitation

T helper cells expressing fractalkine receptor and bearing T follicular helper 1-like cell functions in patients with IgG4-related disease.
Inoue Yoshino, Nakayamada Shingo, Kubo Satoshi, Yamagata Kaoru, Sonomoto Koshiro, Iwata Shigeru, Miyazaki Yusuke, Tanaka Yoshiya
Rheumatology (Oxford, England), Aug. 2022, Reviewed, No invitation

Efficacy and safety of belimumab during maintenance therapy in patients with systemic lupus erythematosus.
Miyazaki Yusuke, Nakayamada Shingo, Sonomoto Koshiro, Akio Kawabe, Inoue Yoshino, Okubo Naoaki, Iwata Shigeru, Hanami Kentaro, Tanaka Yoshiya
Rheumatology (Oxford, England), Aug. 2021, Reviewed, No invitation
Lead

mTOR activation in CD8+ cells contributes to disease activity of rheumatoid arthritis and increases therapeutic response to TNF inhibitors.
Zhang Mingzeng, Iwata Shigeru, Sonomoto Koshiro, Ueno Masanobu, Fujita Yuya, Anan Junpei, Miyazaki Yusuke, Ohkubo Naoaki, Sumikawa Maiko Hajime, Todoroki Yasuyuki, Miyata Hiroko, Nagayasu Atsushi, Kanda Ryuichiro, Trimova Gulzhan, Lee Seunghyun, Nakayamada Shingo, Sakata Kei, Tanaka Yoshiya
Rheumatology (Oxford, England), Nov. 2021, Reviewed, No invitation

Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTD.
Todoroki Yasuyuki, Kubo Satoshi, Nakano Kazuhisa, Miyazaki Yusuke, Ueno Masanobu, Satoh-Kanda Yurie, Kanda Ryuichiro, Miyagawa Ippei, Hanami Kentaro, Nakatsuka Keisuke, Saito Kazuyoshi, Nakayamada Shingo, Tanaka Yoshiya
Rheumatology (Oxford, England), Mar. 2022, Reviewed, No invitation

Distinctive association of peripheral immune cell phenotypes with capillaroscopic microvascular patterns in systemic sclerosis.
Kubo Satoshi, Nakayamada Shingo, Miyazaki Yusuke, Yoshikawa Maiko, Yoshinari Hiroko, Satoh Yurie, Todoroki Yasuyuki, Nakano Kazuhisa, Satoh Minoru, Smith Vanessa, Cutolo Maurizio, Tanaka Yoshiya
Rheumatology (Oxford, England), Jun. 2019, Reviewed, No invitation

Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis.
Nakayamada Shingo, Kubo Satoshi, Yoshikawa Maiko, Miyazaki Yusuke, Yunoue Naoki, Iwata Shigeru, Miyagawa Ippei, Hirata Shintaro, Nakano Kazuhisa, Saito Kazuyoshi, Tanaka Yoshiya
Rheumatology (Oxford, England), Mar. 2017, Null, Null
Corresponding

Effective Second-Line b/tsDMARDs for Patients with Rheumatoid Arthritis Unresponsive to First-Line b/tsDMARDs from the FIRST Registry.
Kanda Ryuichiro, Miyazaki Yusuke, Nakayamada Shingo, Fukuyo Shunsuke, Kubo Satoshi, Miyagawa Ippei, Yamaguchi Ayako, Satoh-Kanda Yurie, Ohkubo Naoaki, Todoroki Yasuyuki, Tanaka Hiroaki, Ueno Masanobu, Nagayasu Atsushi, Fujita Yuya, Aritomi Takafumi, Kusaka Katsuhide, Sakai Hidenori, Matsunaga Satsuki, Nohara Hirotsugu, Tanaka Yoshiya
Rheumatology and therapy, Mar. 2025, Reviewed, No invitation

Influence of Rheumatoid Factors on the Efficacy of TNF Inhibitor Therapy in Patients with Rheumatoid Arthritis.
Nagayasu Atsushi, Miyazaki Yusuke, Sonomoto Koshiro, Kubo Satoshi, Miyagawa Ippei, Yamaguchi Ayako, Tanaka Hiroaki, Todoroki Yasuyuki, Ueno Masanobu, Aritomi Takafumi, Fujita Yuya, Sakai Hidenori, Suzuki Katsunori, Nakayamada Shingo, Tanaka Yoshiya
Rheumatology and therapy, Aug. 2025, Reviewed, No invitation

Efficacy and Safety of Biologics in Polymyalgia Rheumatica: A Retrospective Study.
Ohkubo Naoaki, Miyazaki Yusuke, Nakayamada Shingo, Fukuyo Shunsuke, Inoue Yoshino, Satoh-Kanda Yurie, Tanaka Hiroaki, Todoroki Yasuyuki, Miyata Hiroko, Nagayasu Atsushi, Funada Masashi, Kobayashi Hiroki, Sakai Hidenori, Kosaka Shumpei, Matsunaga Satsuki, Tomoyose Yukiko, Nohara Hirotsugu, Tanaka Yoshiya
Rheumatology and therapy, Oct. 2024, Reviewed, No invitation

Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry.
Kubo Satoshi, Miyazaki Yusuke, Todoroki Yasuyuki, Nagayasu Atsushi, Kanda Ryuichiro, Aritomi Takafumi, Matsunaga Satsuki, Ueno Masanobu, Miyagawa Ippei, Sonomoto Koshiro, Hanami Kentaro, Nakayamada Shingo, Tanaka Yoshiya
Rheumatology and therapy, Oct. 2023, Reviewed, No invitation

Th22 cells promote osteoclast differentiation via production of IL-22.
Miyazaki Y,Nakayamada S,Kubo S,Nakano K,Iwata S,Miyagawa I,Ma X,Trimova G, Sakata K,Tanaka Y.
免疫Immunology Frontier, Apr. 2018, Reviewed, No invitation
Lead

Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus
Sakata K,Nakayamada S,Miyazaki Y,Kubo S,Nakano K,Tanaka Y.
免疫Immunology Frontier, Aug. 2018, Reviewed, No invitation

Efficacy and Safety of Rituximab in Connective Tissue Disease-Associated Thrombotic Thrombocytopenic Purpura/Thrombotic Microangiopathy.
Ohkubo Naoaki, Nakayamada Shingo, Fukuyo Shunsuke, Miyazaki Yusuke, Inoue Yoshino, Tanaka Hiroaki, Todoroki Yasuyuki, Tanaka Yoshiya
International journal of rheumatic diseases, Jun. 2025, Reviewed, No invitation

関節リウマチ患者におけるバリシチニブの有効性と安全性
宮﨑佑介, 田中良哉, Contributor
日本臨床社, Apr. 2022, Reviewed